Serum Interleukin-37 Increases in Patients after Ischemic Stroke and Is Associated with Stroke Recurrence

Figure 6

Serum levels of IL-37 and 3-month functional outcome. (a) Serum levels of IL-37 in stroke patients with poor outcome and good outcome. All data are medians and interquartile ranges (IQR). values refer to Mann–Whitney tests for differences between groups. (b) Receiver operating characteristic (ROC) curves were utilized to evaluate the accuracy of serum IL-37 levels to predict poor outcome.

(a)

(b)